Product Code: RP-ID-10078534 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10078534
Market Overview:
Global Microcarrier Market Size study, by Product (Equipment, Consumables), by Application (Cell Therapy, Vaccine Manufacturing, Biologics Manufacturing, Others) and Regional Forecasts 2018-2025
Global Microcarrier Market to reach USD XX billion by 2025.
Global Microcarrier Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The Microcarrier Market is continuously growing in the global scenario at significant pace. A microcarrier is a supporting matrix used commercially for the growth of adherent cells in bioreactors for biologics production and vaccine manufacturing. Surging demand for cell based vaccines & therapeutics, continuous growth of biologics & biosimilar industry and escalating research & development activities are the substantial driving factors of the market during the forecast period. Moreover, technological advancements associated with microcarrier is the factors that likely to create numerous opportunity in the near future. Further, microcarriers have many advantages such as it allows exceptional scale-up of product and allow cells to grow in three dimensions at high densities which stabilize the cell population and decrease the need for external growth factors. These advantage also rising demand of microcarrier among its end-user industries across the world. However, high cost of biologics & cell-based therapies and slower penetration of microcarrier are the factors that limiting the market growth of Microcarrier during the forecast period.
The regional analysis of Global Microcarrier Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share due to advancement in technology and rising focus on development of cell-based therapies in the region. Further, Europe is estimated second largest market share in the global microcarrier market due to growing demand for microcarrier equipment’s in the region. Asia-Pacific is also anticipated to exhibit higher growth rate/CAGR over the forecast period 2018-2025.
The major market player included in this report are:
• Becton
• Corning Inc.
• Danaher Corporation
• GE Healthcare
• Lonza Group
• Thermo Fischer Scientific
• Merck KGaA
• Eppendorf AG
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
 Equipment
 Consumables
By Application:
 Cell Therapy
 Vaccine Manufacturing
 Biologics Manufacturing
 Others
By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025
Target Audience of the Global Microcarrier Market in Market Study:
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
Corning Inc.
Danaher Corporation
GE Healthcare
Lonza Group
Thermo Fischer Scientific
Merck KGaA
Eppendorf AG
Related Reports
Proof of Quality & Reliability
